TITLE:
Hemostatic Therapy for Intracerebral Hemorrhage
AUTHORS:
Xingxia Wang, Jie Gong, Ping Gu, Zhibao Zhao, Qingwen Jin
KEYWORDS:
Nimodipine, Intracerebral Hemorrhage, Hypertension, Cranial Hypertension
JOURNAL NAME:
Open Journal of Modern Neurosurgery,
Vol.7 No.4,
September
7,
2017
ABSTRACT: Objective: To
reduce the blood pressure and elevate intracranial pressure using nimodipine
(Nimotop Intravenous (IV) infusion). Thus, intracerebral hemorrhage was
controlled, and the purpose of hemostasis was achieved. Methods: Sixty-eight
patients with intracerebral hemorrhage were divided into a treatment group (n =
51), and a control group (n = 35). Nimotop solution (10 mg) was administered as
a fast-flowing IV infusion in the treatment group, and 250 ml 20% mannitol
infusion was given to patients in the control group twice every day. Patients
in both groups received treatment for seven days, and the blood pressure on the
treatment day was measured. A brain Computed Tomography (CT) scan was performed
as a reexamination within two weeks. Results: The blood pressure in the
treatment group was decreased from 179/104 to 151/91 mmHg, averagely, and in
the control group was decreased from 181/108 to 180/103 mmHg, averagely. The
difference between these two groups was statistically significant (P P Conclusion: Nimodipine can
dilate the arteries, reduce blood pressure, and elevate intracranial pressure,
lowering pressure gradients across vessel wall which destroy the vessel wall.
Also, nimodipine can prevent hemorrhage as well as recurrent hemorrhage, and
can used as the first choice of rescue drug. What’s more, dehydration drugs such as mannitol should
not be used in the early stage of intracerebral hemorrhage in order to prevent
hematoma enlargement.